Items stated in the management plan
Annual update| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan 2025 (the successor medium-term management plan is currently being formulated) |
| Progress against the plan | Annual update |
| ROE target | Latest result: 8.2% |
| ROIC target | Not disclosed → ROIC to continuously exceed WACC |
| Payout ratio / DOE policy | From the fiscal year ended March 2025, the company set a target DOE (dividend on equity) of 3% and aims for a dividend payout ratio of at least 30%. This policy will also be implemented from FY2026 onward. |
| Cost of capital | WACC 6.5% |
| Self-assessment of PBR and share price | PBR has generally remained around 1x and was 0.95x in FY2025. The company aims to establish a management structure capable of consistently maintaining PBR above 1x. |
| Investment amount by sector | Field Focused investment in growth businesses / Amount Not disclosed, Field Research and development / Amount Not disclosed |
| Segment target | Segment Growth Businesses / Sales Target At least 50% of consolidated sales / Profit Target Not disclosed |
| Non-financial targets | Indicator GHG Emissions / Target value 30% reduction from FY2019 / Timing FY2030 |
| Key initiatives | Enhancement of shareholder returns, Focused investment in growth businesses and review of existing businesses through the proactive use of ROIC (return on invested capital), Reduction of cross-shareholdings, Dialogue with shareholders |
| Results under the previous plan | Growth businesses to account for at least 50% of consolidated sales; 30% reduction in GHG emissions by FY2030 from FY2019 → Not disclosed |
| Risks identified | Global inflation resulting from the US high-tariff policy, Rising domestic interest rates following the lifting of the negative interest rate policy, Instability in raw-material supplies associated with the situation in the Middle East, Fluctuations in domestic share prices |
| Date of board resolution | 26 April 2024 |
| Publication date | 28 April 2026 |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company proceeded with the acquisition of in vitro diagnostics and materials businesses, the withdrawal from unprofitable overseas businesses, and decisions to transfer its domestic sales businesses for cement and solidifying materials, among others. It explained that the declines in ROE and net income were affected by the recognition of one-off extraordinary losses. It also cited the impact of the US high-tariff policy, rising domestic interest rates, and instability in raw-material supplies associated with the situation in the Middle East.